AMY TURNURE: Open Payments
NPI 1902146376 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,327 in 66 payments from 18 companies in 2025. Trend: 2023 $1,199 · 2024 $1,527 · 2025 $1,327
Food & beverage: $1,327
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $267 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $165 |
| PFIZER INC. | 9 | $159 |
| Novo Nordisk Inc | 8 | $142 |
| Otsuka America Pharmaceutical, Inc. | 6 | $125 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $60 |
| Dexcom, Inc. | 3 | $56 |
| Lilly USA, LLC | 3 | $51 |
| Astellas Pharma US Inc | 2 | $49 |
| GlaxoSmithKline, LLC. | 2 | $40 |
Products named: AIRSUPRA, JARDIANCE, REXULTI, Rybelsus, PREVNAR 20, CAPLYTA, Dexcom G6 Transmitter, Veozah.
Industry payments across TN — which companies pay providers there.
